Article
TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response.
Neuroscience letters - 1 Jan 2010
Viikki Merja, Kampman Olli, Illi Ari, Setälä-Soikkeli Eija, Anttila Sami, Huuhka Martti, Nuolivirta Timo, Poutanen Outi, Mononen Nina, Lehtimäki Terho, Leinonen Esa
Abstract excerpt
The association between the tryptophan hydroxylase 1 (TPH1) 218A/C polymorphism and (1) severity of major depressive disorder (MDD) and (2) response to treatment was studied. There were three study populations, the first consisting of 119 treatment-resistant MDD inpatients treated with electro-convulsive therapy (ECT), and the second of 98 MDD open care patients treated with selective serotonin reuptake...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
